Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 136 to 150 of 489 results for 2011

  1. NICE highlighted the importance of collecting further data within registries of patients receiving biological treatments for psoriatic arthritis to obtain information on long-term outcomes, including adverse events.

    of psoriatic arthritis Number TA220 Date issued April 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  2. Research should be carried out to compare the clinical effectiveness of bendamustine with chlorambucil at the higher dose used in the Chronic Lymphocytic Leukaemia Trial 4 (CLL4).

    lymphocytic leukaemia Number TA216 Date issued February 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  3. What service delivery models allow people with psychosis and coexisting substance misuse to remain living outside hospital?

    in healthcare settings Number CG120 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  4. Is clozapine clinically and cost effective when compared with other pharmacological interventions for people with psychosis and coexisting substance misuse?

    in healthcare settings Number CG120 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  5. What and how should training be provided to healthcare professionals working with people with psychosis and substance misuse?

    in healthcare settings Number CG120 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  6. Ovarian cancer (advanced): bevacizumab 7.5 mg/kg in combination with paclitaxel and carboplatin for first-line treatment (ESUOM21)

    Summary of the evidence on bevacizumab 7.5 mg/kg with paclitaxel and carboplatin for the first-line treatment of advanced ovarian cancer..

    Evidence summary
    Published
    22 October 2013

  7. How do financial factors (including incentives, pricing and taxation of food and incentives, and pricing for physical activity opportunities) affect food and physical activity choices?

    community-level interventions Number PH35 Date issued May 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  8. Is providing treatment for psychosis and substance misuse services within staffed accommodation more cost-effective than a combination of hospital and home treatment?

    in healthcare settings Number CG120 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  9. Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers (HTG355)

    Evidence-based recommendations on Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers.

    HealthTech guidance
    Last updated
    19 May 2021
    View recommendations

    Sections for HTG355

  10. Research is needed on the impact of treating Alzheimer's disease on mortality and institutionalisation, and to assess the relationship between disease progression and carer utility (quality of life).

    Alzheimer's disease Number TA217 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  11. What is the incidence and prevalence of, and what are the demographic trends in, skin cancer in the UK? (Demographic variables might include whether someone is an outdoor or indoor worker, their skin type and socioeconomic status.)

    Skin cancer prevention Number PH32 Date issued January 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  12. Are interventions for psychosis or substance misuse clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?

    in healthcare settings Number CG120 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  13. Are interventions for psychosis or substance misuse clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?

    in healthcare settings Number CG120 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  14. How do socioeconomic, environmental, biological and psychosocial factors determine diet and physical activity behaviours and how do they contribute to differences in the risk of developing type 2 diabetes?

    community-level interventions Number PH35 Date issued May 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  15. Collection and publication of data on the outcomes of percutaneous cryotherapy for renal cancer in the long term is encouraged. Further research should compare the long-term outcomes of cryotherapy with those of other treatments for renal cancer.

    cryotherapy for renal cancer Number IPG402 Date issued July 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015